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Polychlorinated biphenyls (PCBs) are industrial
chemicals consisting of paired phenyl rings
with various degrees of chlorination (Chana
et al. 2002). Although the production of PCBs
was banned in the mid-1970s, these contami-
nants are routinely detected in the environment
(Breivik et al. 2002). The chemical stability and
lipophilicity of these compounds allow them to
bioaccumulate through the food chain, and
they are found in high concentrations in sam-
ples of human tissues (Fisher 1999). A number
of epidemiologic studies have indicated that
children developmentally exposed to PCBs suf-
fer from neuropsychologic deficits such as a
lower full-scale IQ, reduced visual recognition
memory, attention deﬁcits, and motor deﬁcits
(Ayotte et al. 2003; Huisman et al. 1995;
Jackson et al. 1997; Korrick and Altshul 1998;
Osius et al. 1999; Walkowiak et al. 2001).
Both postnatal and prenatal exposure to PCBs
contributes to these deficits, although some
authors argue that prenatal exposure is more
strongly associated with neurologic deficits,
which indicates that fetal neurodevelopment is
particularly vulnerable to PCB exposure
(Jacobson and Jacobson 2002).
The specific neuropsychologic domains
affected by developmental exposure to PCBs
overlap with those affected by maternal thy-
roid hormone (TH) insufficiency, including
lower IQ, visual memory deﬁcits, and motor
function and attention deﬁcits (Haddow et al.
1999; Morreale de Escobar et al. 2000; Pop
et al. 1999). Therefore, several investigators
have speculated that PCBs may affect brain
development by interfering with TH signaling
(McKinney and Waller 1998; Porterfield
2000; Porterfield and Hendry 1998). This
hypothesis is supported by the observation that
the concentrations of PCBs, or of speciﬁc PCB
congeners, in maternal and cord blood are
associated with lower TH levels in both the
mother and infant (Koopman-Esseboom et al.
1994; Schantz et al. 2003). Although several
epidemiologic studies have failed to identify an
association between TH and PCB body bur-
den (Hagmar et al. 2001; Longnecker et al.
2000; Matsuura and Konishi 1990; Sala et al.
2001; Steuerwald et al. 2000), experimental
studies consistently find that PCB exposure
decreases circulating levels of thyroxine (T4) in
rats (Bastomsky 1974; Bastomsky et al. 1976;
Brouwer et al. 1998). Therefore, it is possible
that PCB body burden is negatively associated
with serum TH levels in humans but that the
variability inherent in human populations
makes this association difﬁcult to reveal.
Despite the ﬁnding that PCBs uniformly
reduce circulating levels of TH in experimental
animals, PCBs do not exert effects in experi-
mental animals that are fully consistent with
experimentally produced hypothyroidism
using goitrogens such as propylthiouracil
(PTU). For example, developmental exposure
to PCBs in experimental animals induces
hearing loss (Crofton et al. 2000a, 2000b;
Goldey et al. 1995a, 1995b), a reduction in
choline acetyltransferase in the cerebral cortex
(Juarez de Ku et al. 1994), and an increase in
testicular growth, all consistent to some degree
with effects produced by PTU. Moreover, T4
replacement can at least partially ameliorate
these effects (Goldey and Crofton 1998;
Juarez de Ku et al. 1994), indicating that PCBs
can influence brain development in part by
causing a reduction in serum TH. However,
developmental hypothyroidism induced by
PTU exposure causes a signiﬁcant increase in
serum concentrations of thyroid-stimulating
hormone (thyrotropin; TSH) (Connors and
Hedge 1981), reduced body and brain weight
as well as reduced brain size of rat pups
(Schwartz 1983), and a delay in eye opening
and tooth eruption (Varma et al. 1978). In
contrast, PCB exposure at doses that lower
serum TH does not always produce these
effects (Goldey et al. 1995a; Hood and
Klaassen 2000; Kolaja and Klaassen 1998;
Zoeller et al. 2000). Therefore, there is a dis-
crepancy between the ability of PCBs to
reduce circulating levels of TH and their abil-
ity to produce symptoms of hypothyroidism.
Some authors have proposed that this dis-
crepancy may be attributable to PCBs acting as
imperfect agonists/antagonists on TH recep-
tors (TRs) (McKinney and Waller 1994). TRs
are members of the steroid/thyroid superfamily
of ligand-dependent transcription factors
(Mangelsdorf et al. 1995). They are encoded
by two genes, designated α and β c-erbA
(encoding TRα and TRβ) (Sap et al. 1986;
Weinberger et al. 1986). Both genes are alter-
natively spliced in a tissue-specific manner,
Address correspondence to R.T. Zoeller, Biology
Department, Molecular and Cellular Biology
Program, University of Massachusetts, Amherst, MA
01003 USA. Telephone: (413) 545-2088. Fax: (413)
545-3243. E-mail: tzoeller@bio.umass.edu
We thank D. Darling and J. Meyer for their techni-
cal advice and R. Burch, A. Dowling, and D. Sharlin
for comments on early versions of the manuscript. 
This work was supported by grants ES10026 (R.T.Z.)
and P42 ES 07380 (L.W.R. and H.-J.L.) from the
National Institute of Environmental Health Sciences
and grant T32MH47538 (K.G.) from the National
Institute of Mental Health.
The authors declare they have no competing ﬁnancial
interests.
Received 14 August 2003; accepted 22 December
2003.
Polychlorinated Biphenyls (PCBs) Exert Thyroid Hormone-like Effects in the
Fetal Rat Brain but Do Not Bind to Thyroid Hormone Receptors
Kelly J. Gauger,1 Yoshihisa Kato,2 Koichi Haraguchi,3 Hans-Joachim Lehmler,4 Larry W. Robertson,4 Ruby Bansal,1
and R. Thomas Zoeller1
1Biology Department, Molecular and Cellular Biology Program, Morrill Science Center, University of Massachusetts, Amherst,
Massachusetts, USA; 2School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan; 3Daiichi College of Pharmaceutical
Sciences, Fukuoka, Japan; 4Department of Occupational and Environmental Health, University of Iowa, College of Public Health, Iowa
City, Iowa, USA
Polychlorinated biphenyls (PCBs) are ubiquitous environmental contaminants routinely found in
human and animal tissues. Developmental exposure to PCBs is associated with neuropsychologic
deﬁcits, which may be related to effects on thyroid hormone (TH) signaling in the developing brain.
However, PCBs may interfere with TH signaling solely by reducing circulating levels of TH, or they
may exert direct effects on TH receptors (TRs). Therefore, we tested whether maternal exposure to a
commercial PCB mixture, Aroclor 1254 (A1254), exerts effects in the fetal brain by one or both of
these mechanisms. Dams were dosed daily with 0, 1, or 4 mg/kg A1254 from gestational day 6
(GD6) until they were sacriﬁced on GD16. A1254 signiﬁcantly reduced circulating levels of tri-
iodothyronine (T3) and thyroxine (T4) in pregnant rats but increased the expression of several TH-
responsive genes in the fetal cortex, including neuroendocrine-specific protein A (NSP-A),
RC3/neurogranin, and Oct-1. These ﬁndings are consistent with a direct action of PCBs on TRs.
However, we did not identify parent PCB congeners or metabolites that bound to rat TRs isolated
from hepatic nuclei. These ﬁndings indicate that PCBs can interfere with TH signaling in the fetal
brain by direct actions on the fetus rather than by producing maternal hypothyroidism. Key words:
brain development, endocrine disruption, NSP-A, NSP-C, Oct-1, PCBs, RC3/neurogranin, thyroid,
thyroid hormone. Environ Health Perspect 112:516–523 (2004). doi:10.1289/ehp.6672 available via
http://dx.doi.org/ [Online 22 December 2003]producing a variety of functional TR isoforms
(TRβ1, TRβ2, TRβ3, TRα1) (Flamant and
Samarut 2003). TRα1 and TRβ1 are the pre-
dominant isoforms that are expressed through-
out brain development (Bradley et al. 1989,
1992, 1994) and in other tissues such as liver,
intestine, and heart (Brent 2000). However,
only one report has addressed this proposal
directly (Cheek et al. 1999), ﬁnding that two
hydroxylated PCB congeners (4´-OH-PCB-14
and 4´-OH-PCB-106) exhibit a relatively low
afﬁnity for human TRβ1 (Ki = 32 µM).
Considering these findings, the present
studies were initiated for two reasons. First, we
tested the hypothesis that maternal PCB expo-
sure could affect the fetal cerebral cortex by
reducing the availability of TH to the fetus.
We previously showed that low maternal TH,
produced experimentally by goitrogen treat-
ment, can alter gene expression in the fetal
cortex before the onset of fetal thyroid func-
tion (Dowling et al. 2000, 2001; Dowling and
Zoeller 2000). Therefore, if PCBs reduce cir-
culating levels of maternal TH, then gene
expression in the fetal cortex should respond
in a manner consistent with hypothyroidism.
Second, we tested the hypothesis that individ-
ual PCBs or their metabolites could bind to
the TR. To test this, we used rat hepatic
nuclei as a source of both TRα1 and TRβ1.
Materials and Methods
Chemicals. Aroclor 1254 (A1254; lot no.
A8110048) and individual PCB congeners
(PCBs 77, 105, 118, 126, 138, and 153) were
purchased from AccuStandard, Inc. (New
Haven, CT). Methylsulfonyl-PCBs (MeSO2-
PCBs) were synthesized according to Haraguchi
et al. (1987). The purity of these compounds
was > 99% as determined by gas chromatog-
raphy. The hydroxylated PCBs were synthesized
using the Suzuki coupling of chlorobenzene
boronic acids with bromochloro anisoles fol-
lowed by demethylation with boron tribromide.
The characterization and purity of these com-
pounds have been described previously (Bauer
et al. 1995; Lehmler and Robertson 2001).
Animals. All procedures were performed in
accordance with the National Institutes of
Health Guide for the Care and Use of
Laboratory Animals (Institute of Laboratory
Animal Resources 1996) and were approved
by the University of Massachusetts-Amherst
Institutional Animal Care and Use Committee
before initiating these studies. Timed-pregnant
Sprague-Dawley rats (n = 18; Zivic-Miller,
Inc., Pittsburgh, PA) arrived in our animal
facility 2 days after insemination [gestational
day (GD) 2]. The animals were individually
housed in plastic cages with food and water
provided continuously and were maintained
on a 12:12-hr light cycle (0600 hr to 1800 hr).
All dams were provided daily with a Keebler
Golden Vanilla Wafer (The Kellog Company,
Battlecreek, MI) dosed with A1254 on GD6
through GD16. The wafers were calibrated to
provide doses of 0, 1, and 4 mg/kg (n =
6/group); details of this method have been
described previously (Zoeller et al. 2000).
On GD16, dams were euthanized with
carbon dioxide, and trunk blood was collected
for measurement of serum total T4 by radio-
immunoassay (RIA). The pregnant uterine
horns were removed and immediately placed
on ice. Fetuses were dissected from the uterus,
frozen on pulverized dry ice, and stored at
–80°C until cryosectioned.
In situ hybridization. The NSP-A cDNA
construct and NSP-C oligonucleotide probes
have been described previously (Dowling et al.
2001), and the RC3/neurogranin construct
(pPRC/CMV-RC3) was kindly provided by
J. Bernal (Madrid, Spain; Iniguez et al. 1996).
A fragment of rat Oct-1 transcript was cloned
by standard polymerase chain reaction meth-
ods using primers designed to amplify a 1.2-kb
region of the gene (246–1481, GenBank acces-
sion number U17013; National Center for
Biotechnology Information, Bethesda, MD).
The forward (5´-GCACCCAACCAC-
CAACTTGC-3´) and reverse (5´-GGTGC-
CATCAGGCCTGGATT-3´) primers were
synthesized by Custom Primers (Invitrogen,
Inc., Carlsbad, CA). The 1.2-kb fragment was
then ligated into the pCRII TOPO vector
using the Topo TA cloning kit according to
the manufacturer’s instructions (Invitrogen),
and its authenticity was conﬁrmed by sequence
analysis.
Probes were generated in vitro by lineariza-
tion with the restriction enzymes and tran-
scription with the RNA polymerases speciﬁed
for each construct (Table 1). Transcription
reactions and in situ hybridization procedures
have been described previously (Zoeller et al.
1997). After in situ hybridization, slides were
arranged in X-ray cassettes and apposed to
BioMax ﬁlm (Eastman Kodak Co., Rochester,
NY); the duration of exposure was dependent
on the specific activity of the probe and the
abundance of the target mRNA (2 weeks for
the RC3/neurogranin cRNA probe, 1 week
for the Oct-1 and NSP-A cRNA probes, and
2 days for the NSP-C oligonucleotide probe).
To verify that the ﬁlms were not overexposed,
14C-labeled standards (American Radiolabeled
Chemicals Inc., St. Louis, MO) were simulta-
neously apposed to all films. The hybridiza-
tion signal was analyzed as follows. First, a 5×
magnified image was captured using a Scion
AG-5 capture board interfaced with the public
domain software NIH-Image 1.61/ppc (W.
Rasband, National Institute of Mental Health,
Bethesda, MD) run on a Macintosh G4 com-
puter (Apple Computer Inc., Cupertino, CA).
The optical system consisted of a Dage-
MTI72 series video camera equipped with a
Nikon macro lens mounted onto a bellows
system over a light box. Measurements of rela-
tive mRNA levels were taken as the area of the
signal over the cortex of GD16 fetal brains
multiplied by the relative density of the ﬁlm
(Figure 1). The resulting values were averaged
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Figure 1. Film autoradiographic image of NSP-A
expression in the GD16 fetal brain illustrating the
region of the cortex in which gene expression was
measured. Fetal brain tissue was collected from
the cortex by taking 12-µm horizontal sections. The
top of the image is rostral, the lower portion of the
image is caudal, and the fourth ventricle is labeled
for orientation (V4). Using imaging software, the
signal within the boxed region was delineated, and
the area and density of this region of interest were
then measured for each of eight sections taken
from a single brain. Inset: Pseudocolor (signal
intensity: red > yellow > blue > black) illustrates
the mRNA expression pattern specific to each
TH-responsive gene. Bar = 1.0 mm.
Table 1. Characteristics of plasmids used to prepare cRNA probes for in situ hybridization.
Target Enzyme for Transcript Gene target
mRNA Plasmid Strand linearization Promoter size region Reference
RC3 PRC/CMV Antisense Hind III Sp6 337 253–486 Iniguez et al. 1996
Sense Apa IT 7 344
NSP-A PCR-II Antisense BamH1T 7 202 1946–2147 Dowling et al. 2001
Sense EcoR V Sp6 210
Oct-1 PCR-II Antisense Hind III T7 1226 246–1481 Gauger et al. 2002
Sense Xho I Sp6 1234
NSP-C Synthetic oligo Antisense NA NA NA 230–183 Dowling et al. 2001
NA, not applicable.across eight sections for each fetus, with one
fetus per litter and six litters per treatment
group.
Radioimmunoassay. Total T4 was meas-
ured in 5 µL of rat serum using a barbital
buffer system. Briefly, each assay tube con-
tained 100 µL barbital buffer (0.11 M barbital,
pH 8.6; 0.1% wt/vol 8-anilino-1-naphthalene-
sulfonic acid ammonium salt; 15% bovine
γ-globulin Cohn fraction II; 0.1% gelatin),
100 µL anti-T4 (rabbit, diluted to provide a
final concentration of 1:30,000; Sigma, St.
Louis, MO), and 100 µL 125I-labeled T4
(Perkin-Elmer/NEN; Boston, MA). Standards
were prepared from T4 (Sigma) measured
using a Cahn electrobalance; standards were
run in triplicate, whereas samples were run in
duplicate. Standards were calibrated to mea-
sure serum T4 levels from 0.4 µg/dL to
25.6 µg/dL. Tubes were incubated at 37°C for
30 min and then chilled on ice for 30 min.
Bound counts were precipitated by adding 300
µL ice-cold polyethylene glycol 8000 (20%
wt/wt; Sigma). Tubes were centrifuged at 1800
× g for 20 min at 4°C; the supernatant was
then aspirated and the pellet counted in a
gamma counter (Packard Cobra II; Global
Medical Instrumentation, Inc., Albertville,
MN). The assay was run at 40–50% binding;
nonspeciﬁc binding was generally < 8%. The
assay was validated for rat serum by demon-
strating parallelism between the standard curve
and a dilution series of rat serum. The two
slopes did not vary signiﬁcantly as evaluated by
t-test for two slopes (data not shown). The
variability within the assay was determined by
running 10 replicates of three different stan-
dards that represent a low, medium, and high
value on the standard curve. The coefﬁcients of
variance were 0.9% for 0 ng/mL; 4.7% for 3.2
µg/dL, and 3.8% for 25.6 µg/dL. All experi-
mental samples were evaluated in a single assay.
Total triiodothyronine (T3) was measured
according to the manufacturer’s instructions
using a T3 RIA kit (ICN Diagnostics, Costa
Mesa, CA). This assay was performed at 49%
binding with detection limits of 50–800 ng/dL.
All samples were evaluated in a single assay.
Isolation of hepatic nuclei. Adult male
Sprague-Dawley rats were euthanized with
carbon dioxide and perfused with ice-cold
saline through the aorta until the liver was
cleared of blood. Twenty grams of liver was
then washed in 3 mM MgCl2 and 0.14 M
NaCl, minced, and homogenized in 3 mM
MgCl2, 1 mM dithiothreitol (DTT), and
0.32 M sucrose using a motor-driven Teﬂon
mortar and glass pestle. The homogenate was
centrifuged at 600 × g for 10 min, and the
crude nuclear pellet was resuspended in
3 mM MgCl2, 1 mM DTT, and 1.8 M
sucrose. After centrifugation at 53,000 × g for
45 min, the nuclei were resuspended in bind-
ing buffer (3 mM MgCl2; 1 mM DTT;
20 mM Tris HCl, pH 7.6; 0.32 M sucrose;
and 0.3% bovine serum albumin) and stored
at –80°C.
TH binding assay. For saturation analysis,
nuclear isolates frozen in binding buffer were
thawed on ice, and triplicate aliquots (~0.1 g
of the original liver) were incubated with
increasing concentrations of 125I-T3 (1 × 10–10
to 8 × 10–9 M; 3,300 µCi/µg; NEN, Boston,
MA) for 30 min at 37°C. Nonspeciﬁc binding
was determined at each concentration of
125I-T3 (and each competitor concentration)
by performing the assay as described in a par-
allel set of tubes that included the addition of
10,000-fold excess cold T3 (final concentra-
tion 1 × 10–6 M). The reaction was termi-
nated by placing samples on ice and by
adding binding buffer/1% Triton X-100.
Samples were centrifuged at 13,000 × g for
10 min, the supernatant was discarded, and
the nuclear pellet was washed in 1 mL bind-
ing buffer. The bottom of the microfuge tube
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Figure 3. Effect of A1254 treatment on the levels and patterns of NSP-A, Oct-1, RC3/neurogranin, and NSP-C
mRNA expression in the GD16 fetal cortex. (A) Representative pseudocolor autoradiograms obtained after
in situ hybridization (pseudocolor signal intensity: red > yellow > blue > black). (B) Bar graphs showing the
relative abundance of mRNA expression as reﬂected by the mean ± SEM ﬁlm density (Oct-1 and NSP-C),
area (NSP-A), or integrated density (RC3) and are presented as percent control for the purpose of illustra-
tion. Abbreviations: CX, cortex; V, lateral ventricle; VZ, ventricular zone. Measurements were taken from the
VZ for NSP-A and revealed that the relative area of mRNA expression was significantly elevated in the
1 mg/kg and 4 mg/kg treatment groups. The pattern of Oct-1 expression was not specific to the VZ, and
measurements taken in the CX showed a relative increase in the density of Oct-1 mRNA in both the 1 mg/kg
and 4 mg/kg treatment groups. Measurements taken for RC3/neurogranin were also taken in the CX, and
when density measurements were normalized with respect to area (integrated density), an increase in the
level of mRNA expression was detected in the 4 mg/kg A1254 treatment group. All CX measurements
revealed that NSP-C mRNA levels did not differ among treatment groups. Bar = 50 µm. 
*p < 0.05. **p < 0.01 (signiﬁcantly different from control using Bonferroni’s t-test after one-way ANOVA).
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Figure 2. Effect of A1254 treatment on serum concentrations of total T4 (A) and total T3 (B) in dams at the
time they were sacrificed on GD16. Bars represent mean ± SEM; number of animals in each group is
shown within each bar. See Materials and Methods for treatment details. 
*p < 0.05; **p < 0.01 (signiﬁcantly different from control group using Bonferroni’s t-test after one-way ANOVA).containing the pellet was cut off and placed in
a 14 × 70 mm test tube, which was counted in
a gamma counter (Packard Cobra II). For
competitive binding assays, isolated nuclei
were incubated with a ﬁnal concentration of
1 × 10–10 M 125I-T3 and increasing concentra-
tions of competitors (TR agonists: T3, T4,
Triac (triiodothyroacetic acid), and Tetrac
(tetraiodothyroacetic acid, 1 × 10–12 M to 1 ×
10–9 M; PCBs, 1 × 10–9 M to 1 × 10–3 M).
For noncompetitive binding assays, isolated
nuclei were incubated with 1 × 10–10 M 125I-T3
and increasing concentrations (1 × 10–12 M to
1 × 10–6 M) of T3 alone or increasing con-
centrations (1 × 10–12 M to 1 × 10–6 M) of
T3 in the presence of 2 × 10–6 M of competi-
tors. Nonspecific binding was established as
described above.
Statistical analysis. Results were analyzed
using a one-factor analysis of variance
(ANOVA), and post hoc tests, where appro-
priate, were performed by Bonferroni’s t-test,
where the mean squared error term in the
ANOVA table was used as the point estimate
of the pooled variance (SuperAnova Software;
Abacus Concepts, Inc., Berkeley, CA). A test
for outliers was performed on all data; none
were identified. Some samples were lost in
processes; therefore, there are some unequal
cell sizes.
Results
Dams. Exposure to A1254 significantly
reduced circulating levels of total T4 and total
T3 in dams (T4: F(2,15) = 11.031, p = 0.0011;
T3: F(2,14) = 5.772, p = 0.0142; Figure 2).
Post hoc analysis using Bonferroni’s t-test
revealed that dams treated daily with 4 mg/kg
A1254 exhibited T4 levels that were signifi-
cantly lower than those of control animals
(Figure 2A). There was a trend in animals
treated with 1 mg/kg A1254 to exhibit lower
circulating levels of T4, but this did not reach
statistical signiﬁcance (Figure 2A). Moreover,
animals treated with either 1 or 4 mg/kg
A1254 exhibited significantly lower levels of
circulating T3 compared with control animals
(Figure 2B).
Fetal brains. Quantitative analysis of ﬁlm
autoradiograms after in situ hybridization
revealed that PCB exposure selectively affected
TH-responsive genes in the fetal cortex
(Figure 3). We focused on four different
genes. RC3/neurogranin expression was sig-
nificantly higher in the cortex of fetuses
derived from dams treated with 4 mg/kg
A1254 (F(2,15) = 5.423, p = 0.0169). NSP-A
expression was signiﬁcantly elevated in fetuses
derived from dams treated with either 1 or
4 mg/kg A1254 (F(2,13) = 8.212, p = 0.0049),
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Table 2. TH receptor agonists, parent PCB congeners, MeSO2-PCB metabolites, and hydroxylated PCB metabolites tested in competitive TR binding assays. 
Competitor Abbreviation IUPAC nomenclature Ki ±C V
Triiodothyronine T3 L-3,3´,5-Triiodothyronine 8.37 × 10–10 M 12.70%
Thyroxine T4 L-3,3´,5,5´-Tetraiodothyronine 3.74 × 10–9 M 14.40%
Triiodothyroacetic acid Triac 3,3´,3-Triiodothyroacetic acid 1.29 × 10–9 M 17.30%
Tetraiodothyroacetic acid Tetrac 3,3´,5,5´-Tetraiodothyroacetic acid 2.37 × 10–7 M 18.40%
Parent PCBs PCB-77 3,3´,4,4´-TetraCB  ND NA
PCB-105 2,3,3´,4,4´-PentaCB ND NA
PCB-118 2,3´,4,4´,5-PentaCB ND NA
PCB-126 3,3´, 4,4´,5-PentaCB  ND NA
PCB-138 2,2´,3,4´,4´,5´-HexaCB ND NA
PCB-153 2,2´,4,4´,5,5´-HexaCB ND NA
MeSo2-PCBs 3-MeSO2-PCB-49 3-MeSO2-2,2´,4´,5-tetraCB ND NA
4-MeSO2-PCB-49 4-MeSO2-2,2´,4´,5-tetraCB ND NA
3-MeSO2-PCB-70 3-MeSO2-2,3´,4´,5-tetraCB ND NA
4-MeSO2-PCB-70 4-MeSO2-2,3´,4´,5-tetraCB ND NA
3-MeSO2-PCB-87 3-MeSO2-2,2´,3´,4´,5-pentaCB ND NA
3-MeSO2-PCB-101 3-MeSO2-2,2´,4,5,5´-pentaCB ND NA
4-MeSO2-PCB-101 4-MeSO2-2,2´,4,5,5´-pentaCB ND NA
3-MeSO2-PCB-132 3-MeSO2-2,2´,3,4´,5,5-hexaCB ND NA
3-MeSO2-PCB-141 3-MeSO2-2,2´,3´,4´,5,5´-hexaCB ND NA
3-MeSO2-PCB-149 3-MeSO2-2,2´,4´,5,5,6-hexaCB ND NA
4-MeSO2-PCB-149 4-MeSO2-2,2´,4´,5,5,6-hexaCB ND NA
4-MeSO2-PCB-52 4-MeSO2-2,2´,4,4´-tetraCB ND NA
3-MeSO2-PCB-77 3-MeSO2–3´,4,4´,5-tetraCB ND NA
3-MeSO2-PCB-105 3-MeSO2-2´,3´,4,4´,5-pentaCB ND NA
3-MeSO2-PCB-118 3-MeSO2-2´,4,4´,5,5´-pentaCB ND NA
3-MeSO2-PCB-156 3-MeSO2-2´,3´4,4´,5,5´-hexaCB ND NA
Hydroxylated PCBs 4´-OH-PCB-3 4´-OH-4-monoCB ND NA
4´-OH-PCB-9 4´-OH-2,5-diCB ND NA
4-OH-PCB-14 4´-OH-3´,5´-diCB ND NA
4´-OH-PCB-12 4´-OH-3,4-diCB ND NA
4-OH-PCB-30 4´-OH-2,4,6-triCB ND NA
4´-OH-PCB-34 4´-OH-2,3´,5´-triCB ND NA
4´-OH-PCB-36 4´-OH-3,3´,5-triCB ND NA
4´-OH-PCB-20 4´-OH-2,3,3´-triCB ND NA
4´-OH-PCB-35 4´-OH-3,3´,4-triCB ND NA
4-OH-PCB-39 4-OH-3,4´,5-triCB ND NA
4´-OH-PCB-58 4´-OH-2,3,3´,5´-tetraCB ND NA
4´-OH-PCB-72 4´-OH-2,3´,5,5´-tetraCB ND NA
4´-OH-PCB-106 4´-OH-2,3,3´,4,5-pentaCB ND NA
4´-OH-PCB-112 4´-OH-2,3,3´,5,6-pentaCB ND NA
4´-OH-PCB-159 4´-OH-2,3,3´,4,5,5´-hexaCB ND NA
4´-OH-PCB-165 4´-OH-2,3,3´,5,5´,6-hexaCB ND NA
3´,4´-(di)OH-PCB-12 3´,4´-OH-3,4-diDB ND NA
3´,4´-(di)OH-PCB-3 3´,4´-OH-4-monoCB ND NA
3´-OH-PCB-3 3´-OH-4-monoCB ND NA
2´-OH-PCB-3 2´-OH-4-monoCB ND NA
Abbreviations: CB, chlorinated biphenyl; IUPAC, International Union of Pure and Applied Chemistry; NA, not applicable; ND, no detectable binding.as was Oct-1 (F(2,14) = 5.399, p = 0.0183). In
contrast, NSP-C expression in the GD16
cortex was not affected by PCB exposure
(F(2,15) = 0.202, p = 0.819; not signiﬁcant).
TH receptor binding. To test the hypothe-
sis that individual PCB congeners may bind to
TRs to produce the observed effects on gene
expression in vivo, we tested a number of par-
ent PCBs and metabolites for their ability to
bind to the TR (Table 2). To validate the
assay, we ﬁrst performed a saturation analysis
and established that T3 bound to TRs in iso-
lated hepatic nuclei with a Kd of 9.7 × 10–10 ±
2.02 × 10–10 M (Figure 4). We then tested the
ability of T3 and other TR agonists (T4, Triac,
and Tetrac) to displace 125I-T3 from TRs in
hepatic nuclei (Figure 5A); using the Kd
obtained from saturation analyses, a speciﬁc Ki
was calculated for each compound (Table 2).
However, none of the tested parent PCB con-
geners, hydroxylated metabolites, or MeSO2
metabolites signiﬁcantly displaced 125I-T3 in
this assay (Figure 5B). Similarly, noncompeti-
tive binding analysis revealed that parent PCB
congeners, grouped according to their ortho-
substitution pattern, did not alter the afﬁnity
of T3 for TRs in isolated nuclei (Figure 6).
Discussion
The present study demonstrates that the com-
mercial PCB mixture A1254 significantly
reduces serum TH levels, T4, and T3, in preg-
nant rats on GD16. This developmental time
occurs before the onset of thyroid function in
the fetus (Fisher et al. 1977); therefore, it is
reasonable to propose that this PCB-induced
decrement in maternal TH would cause a
reduction in the expression of genes positively
regulated by TH. However, we found that
PCB exposure up-regulated the expression of
genes that are positively regulated by TH.
These ﬁndings indicate that PCBs can activate
TRs, perhaps directly, and the implication is
important because inappropriate activation of
TRs in the developing brain may produce
adverse consequences on brain development
(Kopelman 1983; Rastogi and Singhal 1976,
1979; Zoeller 2003).
Our ﬁnding that A1254 decreased circu-
lating levels of TH in pregnant rats is consis-
tent with previous studies showing that
exposure to A1254, or specific PCB con-
geners, causes a reduction in circulating levels
of total T4 in pregnant rats (Meerts et al.
2002; Morse et al. 1993, 1996). Additionally,
we found that serum total T3 was also reduced
in the dams by A1254, indicating the degree
to which serum T4 was reduced, because
nearly 80% of circulating T3 is derived from
peripheral deiodination of T4 (Taurog 2000).
Although PCB exposure reduced serum T4 in
the dams, several descriptive measures of
hypothyroidism were not altered. For exam-
ple, maternal body weight, weight gain, litter
size, and pup weight were all unaffected by
PCB treatment in this experiment (data not
shown), similar to results of our previous
study (Zoeller et al. 2000). Therefore, like
others, we observed a discrepancy between the
ability of PCB exposure to lower serum TH
levels and its ability to produce symptoms of
hypothyroidism.
The present finding that fetuses derived
from A1254-treated dams exhibited a signiﬁ-
cant increase in RC3/neurogranin and Oct-1
expression represents strong evidence that
PCBs can produce TH-like effects in the fetal
brain because maternal TH increases the
expression of these genes in the fetal brain
(Dowling et al. 2000; Dowling and Zoeller
2000). Considering that A1254 exposure pro-
duced a signiﬁcant reduction in circulating T4
and T3 in the dam, this ﬁnding is fully consis-
tent with the hypothesis that PCBs can directly
activate TRs in the fetal brain. Moreover,
A1254 exerted selective effects on the expres-
sion of TH-responsive genes because NSP-C,
which is not influenced by TH in the fetus
(Dowling et al. 2000, 2001), was not affected
by A1254. Furthermore, previous work in our
laboratory has demonstrated that A1254
increases the expression of myelin basic pro-
tein, a known TH-responsive gene (Farsetti
et al. 1991; Marta et al. 1998; Rodriguez-Pena
et al. 1993), in the cerebellum and RC3/neu-
rogranin in the forebrain of postnatal rats,
despite the ﬁnding that these pups exhibited a
Article | Gauger et al.
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Figure 5. Competitive binding of known TH receptor agonists (A) and parent PCB congeners (B) to isolated
hepatic nuclei. In (A), rat liver nuclear extracts were incubated with 1.0 nM 125I-T3 and increasing concen-
trations (1 × 10–12 M to 1 × 10–6 M) of T3, T4, Triac, or Tetrac; TR agonists displayed an expected order of
binding affinity to isolated nuclei (T3 ≈ Triac > T4 >> Tetrac). In (B), isolated nuclei were incubated with
1.0 nM 125I-T3 and increasing concentrations (1 × 10–9 M to 1 × 10–3 M) of one of the parent PCB congeners;
no parent PCB congener exhibited significant binding to isolated nuclei. (B) is representative of results
obtained from assays that tested hydroxylated and MeSO2-PCB metabolites for their ability to displace
125I-T3 from TRs in hepatic nuclei. These compounds also showed no signiﬁcant binding to nuclear extracts.
All curves are were obtained from results of a single experiment and are representative of three separate
experiments.
Figure 6. Noncompetitive binding analysis of parent
PCB congeners binding to isolated hepatic nuclei.
Assays were performed to determine whether PCBs
present in A1254 were able to alter the afﬁnity TRs
for T3. Isolated nuclei were incubated with 1.0 nM
125I-T3, and increasing concentrations (1 × 10–12 M to
1 × 10–6 M) of T3 alone or with increasing concentra-
tions (1 × 10–12 M to 1 × 10–6 M) of T3 in the presence
of 20 µM of the PCB competitor. These PCBs were
unable to alter the established Ki of T3 for TRs in
hepatic nuclei.
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Figure 4. (A) Saturation analysis of 125I-T3 speciﬁc binding (SB) to TRs in nuclei isolated from rat liver tissue,
and (B) total binding (TB) obtained by incubating hepatic nuclei with increasing concentrations (1 × 10–10 to
8 × 10–9) 125I-T3 (n = 3; see “Materials and Methods” for assay conditions). NSB, nonspeciﬁc binding.Article | PCBs and thyroid hormone action
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severe reduction in the circulating levels of TH
(Zoeller et al. 2000). Taken together, these
data indicate that A1254 can exert agonistic
effects on a variety of positively regulated
TH-responsive genes in different brain regions
at different developmental times.
Although A1254 produced TH-like
effects on the expression of RC3/neurogranin
and on Oct-1 in the fetal cortex in the pre-
sent study, it did not exert these effects on
NSP-A expression. We previously found that
NSP-A expression is signiﬁcantly increased in
the brain of fetal rats derived from hypothy-
roid dams (Dowling et al. 2000, 2001).
Therefore, the present finding that NSP-A
expression is increased in the cortex of fetuses
exposed transplacentally to A1254 suggests
that the expression of this gene is responding
to low maternal T4 in PCB-treated dams, not
to agonistic actions of PCBs on TRs.
Previously, we showed that T4 treatment of
hypothyroid dams did not restore NSP-A
expression in the fetal cortex (Dowling et al.
2001). Because T4 was provided for only a
short time, the interpretation was that the
duration of T4 treatment was not sufﬁcient to
produce a signiﬁcant reduction in cellular lev-
els of NSP-A mRNA. However, Chan et al.
(2003) have recently reported that NSP-A
expression is not directly sensitive to TH in
N-Tera-2 cells, indicating that NSP-A may
not be directly regulated by TH. If maternal
hypothyroidism increases NSP-A expression
indirectly, and NSP-A is not directly regu-
lated by TH, then our present results indicate
that PCBs produce effects on the fetal brain
by exerting direct TH-like effects as well as by
inducing low maternal TH.
Considering these findings, we tested a
number of PCB congeners and specific
metabolites for their ability to bind to TRs
using a well-established binding assay
(DeGroot and Torresani 1975). We found
that neither the parent PCB congeners nor the
hydroxylated or MeSO2 metabolites signifi-
cantly displace T3 from rat hepatic nuclei. It is
not likely that these observations are false nega-
tives because the observed Ki for several control
ligands, including T3, T4, Tetrac, and Triac,
were all within the published range (Evans and
Braverman 1986; Goslings et al. 1976;
Ichikawa and DeGroot 1987). In addition, we
demonstrated in preliminary studies that the
PCB diluent (dimethyl sulfoxide) does not
interfere with the assay; moreover, we used
different diluents in initial studies and
obtained results that did not differ from those
reported here. Thus, our ﬁnding that individ-
ual PCB congeners or their metabolites do not
displace T3 from its receptor indicates that
these compounds do not interact with the TR
in a competitive manner.
We employed hepatic nuclei to test
whether individual PCB congeners could
bind to rat TRs because the TR isoforms
expressed in hepatocytes are also the predomi-
nant isoforms expressed in the fetal cortex
(Bradley et al. 1992; Nakai et al. 1988).
Therefore, the observation that individual
PCB congeners did not displace T3 from liver
nuclei suggests that they also do not displace
T3 from TRs in the fetal cortex. However,
Cheek et al. (1999) demonstrated that several
hydroxylated PCB metabolites bind to the
human TRβ1, although the affinity for the
TR was reported to be 10,000-fold lower
than that of T3. We evaluated two of these
metabolites, 4´-OH-PCB-14 and 4´-OH-
PCB-106, but did not find significant bind-
ing to the TRs in rat hepatic nuclei. These
two studies may differ in their findings
because we used TR isoforms from a different
species, or because both TRα1 and TRβ1 are
expressed in hepatocytes (Nakai et al. 1988).
Specifically, it is possible that we may not
have observed signiﬁcant T3 displacement if a
PCB congener binds to only one of the two
TRs with low afﬁnity.
There are two major implications of the
present study. First, the observation that PCB
exposure selectively alters gene expression in
the fetal cortex strongly suggests that PCBs
can exert deleterious effects on fetal brain
development regardless of the mechanism by
which this effect is mediated. Because we used
TH-responsive genes as end points for this
study, it is likely that the observed effects
reflect the ability of PCBs to disrupt TH
action in the fetal brain. It will be important
to determine whether PCB exposure can
interfere with neurodevelopmental events by
interfering with TH action.
The second major implication of our
present results is that PCBs do not appear to
bind to TRs in a competitive manner. We
were surprised to find no individual PCB
congeners or metabolites that exhibited
strong binding to TRs, especially consider-
ing previous speculation about this
(McKinney et al. 1987; McKinney and
Waller 1998; Porterfield 1994, 2000;
Porterfield and Hendry 1998). However,
there is evidence that PCB congeners can
affect TR activation without displacing T3.
Speciﬁcally Iwasaki et al. (2002) showed that
4´-OH-PCB-106 suppressed T3-induced
transactivation by TR in various cell lines.
This appeared to be specific to the TR
because it did not suppress glucocorticoid
receptor–mediated transactivation. In addi-
tion, they showed that this PCB congener
suppressed the ability of the TR to recruit
the coactivator SRC-1. Because we found
that this hydroxylated PCB did not displace
T3 from rat TRs in the present study, these
observations strongly suggest that PCBs can
directly alter TR action by a mechanism that
is not well understood.
Our failure to identify individual PCBs
that can bind with high afﬁnity to the rat TRs
requires alternate explanations for their effects
on TH-responsive genes and developmental
events. Individual PCB congeners may alter
TH metabolism by tissue deiodinases, thereby
changing the amount of hormone available to
the TR. Previous studies indicate that PCBs
can increase type-2 deiodinase activity in the
adult (Hood and Klaassen 2000) and fetal
(Meerts et al. 2002; Morse et al. 1996) rat
brain. Moreover, PCBs are also known to
affect second messenger signaling in the brain
by affecting calcium homeostasis, receptor-
mediated inositol phosphate production, and
translocation of protein kinase C (Kodavanti
et al. 1993, 1994). In addition, PCBs can
produce toxic effects by binding either to the
aryl hydrocarbon receptor (Safe 1990) or the
ryanodine receptor (Schantz et al. 1997;
Wong et al. 1997). These studies demonstrate
that PCBs, especially as a mixture such as
A1254, clearly produce multiple effects.
However, there is no evidence that these
other mechanisms of PCB action can exert
speciﬁc effects on TH-responsive genes.
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